Georgia Erbez - Net Worth and Insider Trading
Georgia Erbez Net Worth
The estimated net worth of Georgia Erbez is at least $402,381 dollars as of 2024-12-28. Georgia Erbez is the CFO of Harpoon Therapeutics Inc and owns about 9,821 shares of Harpoon Therapeutics Inc (HARP) stock worth over $225,981. Georgia Erbez is the CFO of Raptor Pharmaceutical Corp and owns about 19,600 shares of Raptor Pharmaceutical Corp (RPTP) stock worth over $176,400. Georgia Erbez is also the CFO and Chief Business Officer of Zosano Pharma Corp and owns about 165 shares of Zosano Pharma Corp (ZSANQ) stock worth over $0. Details can be seen in Georgia Erbez's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Georgia Erbez has not made any transactions after 2021-09-22 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Georgia Erbez
Georgia Erbez Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Georgia Erbez owns 6 companies in total, including Harpoon Therapeutics Inc (HARP) , Artelo Biosciences Inc (ARTL) , and Zosano Pharma Corp (ZSANQ) among others .
Click here to see the complete history of Georgia Erbez’s form 4 insider trades.
Insider Ownership Summary of Georgia Erbez
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| HARP | Harpoon Therapeutics Inc | 2021-09-22 | Chief Financial Officer |
| ARTL | Artelo Biosciences Inc | 2019-06-21 | director |
| ZSANQ | Zosano Pharma Corp | 2017-05-25 | Interim CFO |
 | | 2015-11-09 | Exec VP & CFO |
| | 2014-05-13 | Chief Financial Officer |
| | 2021-06-02 | director |
Georgia Erbez Latest Holdings Summary
Georgia Erbez currently owns a total of 3 stocks. Among these stocks, Georgia Erbez owns 9,821 shares of Harpoon Therapeutics Inc (HARP) as of September 22, 2021, with a value of $225,981 and a weighting of 56.16%. Georgia Erbez owns 19,600 shares of Raptor Pharmaceutical Corp (RPTP) as of May 13, 2014, with a value of $176,400 and a weighting of 43.84%. Georgia Erbez also owns 165 shares of Zosano Pharma Corp (ZSANQ) as of May 25, 2017, with a value of $0 and a weighting of 0%.
Latest Holdings of Georgia Erbez
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| HARP | Harpoon Therapeutics Inc | 2021-09-22 | 9,821 | 23.01 | 225,981 |
| RPTP | Raptor Pharmaceutical Corp | 2014-05-13 | 19,600 | 9.00 | 176,400 |
| ZSANQ | Zosano Pharma Corp | 2017-05-25 | 165 | 0.00 | 0 |
Holding Weightings of Georgia Erbez
Georgia Erbez Form 4 Trading Tracker
According to the SEC Form 4 filings, Georgia Erbez has made a total of 4 transactions in Harpoon Therapeutics Inc (HARP) over the past 5 years, including 4 buys and 0 sells. The most-recent trade in Harpoon Therapeutics Inc is the acquisition of 1,030 shares on September 22, 2021, which cost Georgia Erbez around $83,430.
According to the SEC Form 4 filings, Georgia Erbez has made a total of 0 transactions in Raptor Pharmaceutical Corp (RPTP) over the past 5 years. The most-recent trade in Raptor Pharmaceutical Corp is the acquisition of 16,100 shares on May 13, 2014, which cost Georgia Erbez around $127,190.
According to the SEC Form 4 filings, Georgia Erbez has made a total of 0 transactions in Zosano Pharma Corp (ZSANQ) over the past 5 years. The most-recent trade in Zosano Pharma Corp is the acquisition of 97 shares on May 25, 2017, which cost Georgia Erbez around $89,760.
Insider Trading History of Georgia Erbez
- 1
Georgia Erbez Trading Performance
GuruFocus tracks the stock performance after each of Georgia Erbez's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Georgia Erbez is -1.75%. GuruFocus also compares Georgia Erbez's trading performance to market benchmark return within the same time period. The performance of stocks bought by Georgia Erbez within 3 months outperforms 4 times out of 7 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Georgia Erbez's insider trading performs compared to the benchmark.
Performance of Georgia Erbez
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 11.61 | | | | | |
| Relative Return to S&P 500(%) | 10.15 | | | | | |
Georgia Erbez Ownership Network
Georgia Erbez Owned Company Details
What does Harpoon Therapeutics Inc do?
Who are the key executives at Harpoon Therapeutics Inc?
Georgia Erbez is the Chief Financial Officer of Harpoon Therapeutics Inc. Other key executives at Harpoon Therapeutics Inc include 10 percent owner Vijay K Lathi , Chief Medical Officer Luke Nathaniel Walker , and Principal Fin. & Acctng Ofc. Frank J Lanza .
Harpoon Therapeutics Inc (HARP) Insider Trades Summary
Over the past 18 months, Georgia Erbez made no insider transaction in Harpoon Therapeutics Inc (HARP). Other recent insider transactions involving Harpoon Therapeutics Inc (HARP) include a net purchase of 21,397,205 shares made by Merck & Co., Inc. ,
In summary, during the past 3 months, insiders sold 0 shares of Harpoon Therapeutics Inc (HARP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Harpoon Therapeutics Inc (HARP) were sold and 21,397,205 shares were bought by its insiders, resulting in a net purchase of 21,397,205 shares.
Harpoon Therapeutics Inc (HARP)'s detailed insider trading history can be found in Insider Trading Tracker table.
Harpoon Therapeutics Inc Insider Transactions
Georgia Erbez Mailing Address
Above is the net worth, insider trading, and ownership report for Georgia Erbez. You might contact Georgia Erbez via mailing address: 6300 Dumbarton Circle, Fremont Ca 94555.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
